51. State of The Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma
- Author
-
Romina Grazia Giancipoli, Serena Monti, Brunna Clemente Oliveira, Lorenzo Di Cesare Mannelli, Natally Horvat, and Camila Rocha
- Subjects
Pathology ,medicine.medical_specialty ,Cirrhosis ,magnetic ,R895-920 ,Radiogenomics ,Review ,Chronic liver disease ,liver ,030218 nuclear medicine & medical imaging ,Medical physics. Medical radiology. Nuclear medicine ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Radiology, Nuclear Medicine and imaging ,resonance imaging ,medicine.diagnostic_test ,business.industry ,cirrhosis ,hepatic nodule ,Cancer ,Magnetic resonance imaging ,hepatocellular carcinoma ,medicine.disease ,digestive system diseases ,3. Good health ,Oncology ,Positron emission tomography ,Hepatocellular carcinoma ,030211 gastroenterology & hepatology ,business ,Liver cancer - Abstract
Background Liver cancer is the sixth most common cancer worldwide and the second leading cause of cancer mortality. Chronic liver disease caused by viral infection, alcohol abuse, or other factors can lead to cirrhosis. Cirrhosis is the most important clinical risk factor for hepatocellular carcinoma (HCC) whereby the normal hepatic architecture is replaced by fibrous septa and a spectrum of nodules ranging from benign regenerative nodules to HCC, each one of them with different imaging features. Conclusions Furthermore, advanced techniques including the quantification of hepatic and intralesional fat and iron, magnetic resonance elastography, radiomics, radiogenomics, and positron emission tomography (PET)-MRI are highly promising for the extraction of new imaging biomarkers that reflect the tumor microenvironment and, in the future, may add decision-making value in the management of patients with HCC.
- Published
- 2018